- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Eleanor Perfetto on Ways to Improve Transparency, Education Around Value Assessment
Eleanor M. Perfetto, PhD, MS, senior vice president of Strategic Initiatives for the National Health Council, discusses potential strategies for increasing transparency in value assessment and where education fits into the mix.
Eleanor M. Perfetto, PhD, MS, senior vice president of Strategic Initiatives for the National Health Council, discusses potential strategies for increasing transparency in value assessment and where education fits into the mix.
Transcript
What are some potential strategies for increasing transparency in value assessment?
Transparency is very important in all aspects of healthcare, not just in value assessment. It’s really important that we’re seeing more and more transparency, how calculations are being conducted. Open source—some organizations are making all of their calculations in code open so anybody can take a look at it. Having that flexibility. Being able to really understand what’s being put into an assessment is really important to being able to assess the quality of it and whether or not it should be used in decision making.
How does education fit into this? How important is it to educate patients and empower them to take part in these conversations?
The education part is important on both sides. On the patient side, having them understand what goes into a health economic evaluation, a health technology assessment, or value assessment, that way they can actively participate, have that capacity to engage in the process. But it’s also important on the side of the researchers who are doing the work, for them to understand how to engage patients, how to bring them in, how to use the valuable information that patients can being into the process.
Ruxolitinib Cream Shows Long-Term Safety in AD, Potential for PN Treatment
March 8th 2025Two posters presented at the 2025 American Academy of Dermatology Annual Meeting reaffirmed the impact of ruxolitinib cream (Opzelura; Incyte) in atopic dermatitis (AD), while late-breaking research highlighted its potential efficacy in prurigo nodularis (PN).
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Shaping Dermatology's Future by Increasing Access, Data, and Advocacy
March 7th 2025Thy N. Huynh, MD, FAAD, Bruce A. Brod, MHCI, MD, FAAD, and Melissa Piliang, MD, FAAD, discussed expanding access to pediatric dermatology, dermatology data aggregation, and advocacy for Medicare physician payment reform, respectively.
Read More
